Supply problems at the start of the COVID-19 pandemic sparked concerns about fragile pharmaceutical supply chains. Australia must consider how it can drive forward its domestic industry while also being a strong voice for regional cooperation.
Search results for Membership
In this section
Filter in Search results for Membership
Search in Search results for Membership
521 results